AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
50.24
+0.29 (0.58%)
At close: Feb 10, 2026, 4:00 PM EST
51.80
+1.56 (3.11%)
After-hours: Feb 10, 2026, 7:10 PM EST

AnaptysBio Revenue

AnaptysBio had revenue of $76.32M in the quarter ending September 30, 2025, with 154.26% growth. This brings the company's revenue in the last twelve months to $169.47M, up 196.42% year-over-year. In the year 2024, AnaptysBio had annual revenue of $91.28M with 432.03% growth.

Revenue (ttm)
$169.47M
Revenue Growth
+196.42%
P/S Ratio
8.72
Revenue / Employee
$1,246,081
Employees
136
Market Cap
1.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202491.28M74.12M432.03%
Dec 31, 202317.16M6.87M66.78%
Dec 31, 202210.29M-52.89M-83.72%
Dec 31, 202163.18M-11.83M-15.77%
Dec 31, 202075.00M67.00M837.50%
Dec 31, 20198.00M3.00M60.00%
Dec 31, 20185.00M-5.00M-50.00%
Dec 31, 201710.00M-6.68M-40.06%
Dec 31, 201616.68M-887.00K-5.05%
Dec 31, 201517.57M1.73M10.94%
Dec 31, 201415.84M10.36M188.86%
Dec 31, 20135.48M--